Drug Repositioning: Current Advances and Future Perspectives

Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yuhei Nishimura, Hideaki Hara
Fformat:	Online
Iaith:	Saesneg
Cyhoeddwyd:	Frontiers Media SA 2021
Pynciau:	RM1-950 Q1-390 database Integrative strategies molecular docking polypharmacology multi-omics computational analysis Drug Repositioning data sharing Patenting thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Mynediad Ar-lein:	32072
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!